• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza virus activity in the world, 26 October 2012 (WHO, edited): Increased activity in Central & S. America

Giuseppe

Emeritus
[Source: World Health Organization, full page: (LINK). Edited.]

Influenza virus activity in the world, 26 October 2012

Source: Laboratory confirmed data from the Global Influenza Surveillance and Response System (GISRS).



Based on FluNet reporting (as of 23 October 2012, 15:00 UTC), ), during weeks 40 to 41 (30/09/2012 to 13/10/2012), National Influenza Centres (NICs) and other national influenza laboratories from 93 countries, areas or territories reported data.

The WHO GISRS laboratories tested more than 18 909 specimens.

996 were positive for influenza viruses, of which 575 (57.7%) were typed as influenza A and 421 (42.3%) as influenza B.

Of the sub-typed influenza A viruses, 206 (39.4%) were influenza A(H1N1)pdm09 and 317 (60.6%) were influenza A(H3N2).

Of the characterized B viruses, 16 (72.7%) belong to the B-Yamagata lineage and 6 (27.3%) to the B-Victoria lineage.



Summary

During weeks 40 and 41, influenza activity remained low globally although increased reports of laboratory confirmed influenza positives have been received from some countries in the northern hemisphere. Influenza A(H3N2) viruses remained the predominant subtype globally, followed by influenza B and A(H1N1)pdm09 viruses.

Sporadic detections of influenza viruses have been reported from Europe and North America. In Canada, A(H3N2) and A(H1N1)pdm09 viruses were detected while in the United States of America, influenza B viruses have been predominant followed by A(H3N2) and A(H1N1)pdm09 viruses. In Europe, detections of A(H3N2) and influenza B viruses have been reported.

In Asia, co-circulation of A(H1N1)pdm09 viruses and influenza B viruses continued in India and Nepal. Influenza B viruses remained the predominant subtype in the region. Sporadic detections of influenza A(H1N1)pdm09 and influenza B viruses were reported from Qatar in the Middle East.

In the southern hemisphere, influenza activity has decreased.

Influenza activity was reported to be at baseline level in Australia while no reports of laboratory confirmed influenza positives were received from other countries in Oceania.

In Africa, A(H3N2) continued to circulate throughout central, eastern and western Africa.

In Central and South America, influenza activity increased slightly in Argentina, Brazil and Chile compared to previous weeks. Co-circulation of influenza A(H3N2) and B viruses continued in a few countries throughout the region.
-
------
 
Back
Top Bottom